Rhenium complexes with the antibiotic ciprofloxacin have been prepared to be studied as models of technetium radiopharmaceuticals. With this aim, the new rhenium have shown a very similar behaviour between complex 2 and the free antibiotic, whereas complex 3 exhibit a lower antimicrobial activity.
Introduction
Molecular imaging techniques are very powerful tools in medicine because they allow visualising biochemical process in living organisms by non-invasive methods.
Images can be obtained either by measuring the absorption of externally applied radiation (NMR, CT), or the radiation escaping from the body. In the second case, a diagnostic radiopharmaceutical, a molecule that contains an unstable radionuclide which decomposes with the emission of gamma rays, should be administered to the patient.
The radionuclide Tc-99m is widely used in radiopharmacy for this purpose due to its availability through the 99 Mo/ 99m
Tc generator and its near ideal nuclear properties (halflife of 6h and γ-ray energy of 141 keV). 1, 2 The high penetration ability of photons allows gamma radiation to escape from the body and to be detected externally. The analysis of the in vivo behaviour of the radiopharmaceutical makes it possible to differentiate normal from abnormal anatomical structures or biochemical functions. Current research with technetium radiopharmaceuticals is focused on the development of bioactive substances with specific biological properties linked to the technetium metal. 3, 4 Despite significant advances in medicine, infections remain a major health problem and a cause of patient mortality worldwide. The use of specific radiopharmaceuticals for infection imaging is an attracting approach, as it is a sensitive methodology that allows a site of an occult infection to be located earlier. 5, 6 Radiolabelled leucocytes is currently one of the most commonly used radiopharmaceuticals in hospitals for this purpose, but radiolabelled antimicrobial peptides and radiolabelled antibiotics are also being studied as potential alternatives. 5, 6 Ciprofloxacin is one of the most common and widely used antibacterial agents (Scheme A c c e p t e d m a n u s c r i p t 4 1). It is a synthetic antibiotic belonging to fluoroquinolone group with a broad-spectrum bacteria-localising capability. 7, 8 Fluoroquinolones suppress the growth of bacteria by inhibiting the activity of DNA gyrase, an essential bacterial enzyme that relieves strain while double-stranded DNA is being unwound. 7, 9, 10 Technetium-99m labelled ciprofloxacin ( 99m Tc-ciprofloxacin or Infecton) was first introduced in the 1990s and has been extensively studied as an infection-specific radiopharmaceutical. 5, [11] [12] [13] [14] [15] [16] However, the global analysis of numerous published studies (including clinical trials) shows contradictory data about the specificity of 99m Tc-ciprofloxacin. Thus, different authors have claimed that this radiopharmaceutical can not properly differentiate a bacterial infection from an aseptic inflammation. 5, 15, 16 One of the main problems to elucidate the behaviour of this radiopharmaceutical is that, although it has been studied for two decades, there is no information about its molecular structure. This situation is due to attempts to prepare a model rhenium complex of 99m Tc-ciprofloxacin have been unsuccessful, 17 and the structural analysis of the Tc-99m complex is not possible as it is prepared at very low concentration (10 -7 -10 -8 M). 1,2 If a model rhenium complex was available, the influence of metal coordination in the antibacterial properties of ciprofloxacin could be analyzed, and this is a key point to understand how this compound works as diagnostic radiopharmaceutical. We must realise that, in a first approximation, it seems very strange that the coordination of ciprofloxacin to the metal does not significantly alter its antibacterial properties. Particularly, if we take into account that the atoms that probably interact with the metal (4-oxo carbonyl and carboxylate oxygen atoms) are the same that have been proposed to interact with DNA gyrase. 7, 9 In contrast to this view, other authors have proposed that metal atoms can be involved in the interaction between ciprofloxacin and DNA-gyrase , 7, [18] [19] [20] which could A c c e p t e d m a n u s c r i p t 29 Zr, 29 Mo, 24 Ag, 30 Cd, 21, 26 Pt, 31 U 32 and Eu 33 have been reported, and there is even a review of these metal complexes. 19 As mentioned above, the most common coordination mode of ciprofloxacin is through the oxygen atoms of the 4-oxo carbonyl and the carboxylate groups, forming a chelating ring of six atoms. Only a few examples have been reported, in which the coordination through the nitrogen atoms of the piperazine ring of ciprofloxacin is shown or proposed. 30, 31 As far as we know, only one rhenium complex with a derivative of ciprofloxacin has been reported, 34 but in this case the studied ligand is obtained by a coupling reaction between a tridentate chelator and the piperazinyl nitrogen of ciprofloxacin. This structural modification changes the coordination ability of the molecule and the metal is coordinated to the tridentate chelator, while the carbonyl and the carboxylate groups of ciprofloxacin remain free. The objective of this modification is to obtain a new molecule that preserves the capability of the antibiotic to bind bacteria, and that can also form stable bonds with technetium. Following the same approach, three works with Tc99m have been published that contain other structural modifications of ciprofloxacin. [35] [36] [37] In recent years, and in some cases in conjunction with structural modifications of ciprofloxacin, the substitution of the hypothetical Tc(V) fragment {TcO} 3+ by the technetium tricarbonyl {fac-Tc(CO) 3 } has been explored in order to improve the potential radiopharmaceutical properties of technetium complexes with ciprofloxacin.
34,
A c c e p t e d m a n u s c r i p t The aim of this paper is to prepare rhenium complexes with ciprofloxacin that can be useful as model compounds of 99m Tc-ciprofloxacin to study their antibacterial properties, and to provide valuable data for understanding the behaviour of this radiopharmaceutical. This work will be complemented with a study in which the Re(V)
will be replaced by the rhenium tricarbonyl fragment. This approach will allow us to compare the interaction of the two different fragments with ciprofloxacin and to supply comparative data for their antibacterial properties, which can shed some light on the understanding of the radiopharmaceutical properties of technetium ciprofloxacin derivatives. Part of this work was previously communicated.
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Materials and methods

Starting materials and methods
All reactions were performed under nitrogen using standard Schlenk tube techniques. Infrared spectra were recorded with a Perkin-Elmer 2000 FT spectrometer.
The NMR spectra were recorded in the 45 were prepared by published procedures.
The preparation method for 99 Tc-ciprofloxacin was identical to that previously reported 46 but the technetium concentration was increased to 1.4 nmol/mL (the mass amount of technetium was calculated using algorithms derived from the radioactive equilibriums in the generator 47 ) to improve performance in ESI-MS. This was achieved by radioactive decay of solutions with high activity. The concentration of technetium under these conditions was 10-100 times higher than in the no-carrier added conditions.
The HPLC-MS (ESI) system used for this study consisted of a Liquid Chromatograph (Agillent 1100 HPLC) equipped with a RP C18 column (XTerra MS C18 Waters; 50 × A c c e p t e d m a n u s c r i p t 
Chemical synthesis
Synthesis of 1
The 
Antimicrobial susceptibility test
Antimicrobial activities of the complexes 2 and 3 were evaluated using a methodology similar as previously described. 48, 49 Briefly, 24h cultures of tested A c c e p t e d m a n u s c r i p t
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The diameters of inhibition zones were measured. Ciprofloxacin (5 µg; Oxoid) was used as reference substance.
DNA gyrase cleavage assay
The solutions of complexes were prepared as follow: compound 2 and ciprofloxacin hydrochloride (used as control) were dissolved in sterile MilliQ grade water. Complex 3 was dissolved in a small volume of DMSO and the solution was diluted with sterile MilliQ grade water to the desired assay concentrations (from 1 to 250 µM). In all cases, the DMSO final concentration was less than 2.5 %.
DNA gyrase cleavage assay was carried out following the recommendations of the manufacturer (Inspiralis). Briefly, 0.5 µl (1U) of DNA gyrase was incubated with 0.5 µg of supercoiled pBR322 in a reaction volume of 30µl at 37ºC for 1 hour in a 1X assay buffer (Inspiralis). Ciprofloxacin or the assay complexes (2, 3) were added at the desired concentrations (from 1 to 250 µM). Following, sodium dodecyl sulfate and proteinase K were added to final concentrations of 0.2 % and 0.1 mg/ml, respectively, and the incubation was continued for 30 min at 37 ºC. The reactions were stopped by adding 30
µl Stop buffer (40 % sucrose, 100 mM Tris.HCl (pH 7.5), 100 mM EDTA, 0.5 µg/mL bromophenol blue), followed by extraction with 1 volume of chloroform/isoamyl alcohol temperatures. The hydrothermal reaction was also studied using similar reaction conditions to those reported in the preparation of some ciprofloxacin metal complexes. 19, 21, 28 The worst results were obtained in those tests carried out in hydrothermal conditions, or in acetone as a reaction medium, which led to slightly coloured solutions and the recovery of ciprofloxacin as the main product. In contrast, reactions in methanol gave rise to dark brown solutions, and no significant quantities of The 1 H NMR spectrum of 1 is very similar to the spectrum of free ciprofloxacin, although show some small changes that agree more with the coordination of ciprofloxacin through the oxygen atoms of carboxylate and carbonyl groups than with the coordination through the piperazine ring. Thus, no significant changes are observed in the methylene hydrogens of piperazine ring, 31 whereas slight down field shifts are noticed in the H2, H5 and H8 hydrogen atoms of the quinolone ring. 53 In order to obtain information about the binding mode of ciprofloxacin, the 13 C spectrum is more useful because carbon atoms are directly linked to the heteroatoms susceptible of bonding to the metal. However, attempts to obtain a 13 C NMR spectrum of 1 in solution were unsuccessful because the solubility of this compound is low, which force too long acquisition times in order to observe the signals of atoms of quinolone ring. This long time involves some decomposition of 1, and a slight precipitate of free ciprofloxacin was observed in the NMR tube. Attempts to isolate a monocrystal of complex 1 for Xray analysis were unsuccessful for this same reason. This behaviour forced us to study this complex by solid-state NMR methods using cross-polarization and magic angle spinning experiments (CP-MAS). On comparing the 13 C CP-MAS spectra of complex 1 and ciprofloxacin, small changes in the 0-50 ppm region can be observed (Figure 2 , numbering of carbon atoms is shown in Scheme 1), whereas the most relevant modifications are detected in the 160-180 ppm region. Thus, in free ciprofloxacin a sole signal is observed that has been assigned to the carboxylate and C4 carbon atoms. 22 The coordination of the metal through the oxygen atoms of carbonyl and carboxylate groups exerts a strong influence on these carbon atoms directly bonded to these oxygen and these resonances are observed in the complex 1 as two different peaks. This assignment is consistent with the reported study with complex [Al(CpfH) 3 ]Cl 3 (CpfH = ciprofloxacin).
(Figure 2)
The IR spectrum also suggests ciprofloxacin coordination through the oxygen atoms of carboxylate and carbonyl groups, in accordance with the NMR spectroscopy.
Thus, two intense signals are observed at 1630 and 1454 cm -1 , which have been assigned to the vibrations of carboxylate and ketone groups in previously reported ciprofloxacin metal complexes with the proposed coordination of ciprofloxacin. 19, 29, 54 The presence of an oxorhenium metal fragment in 1 is also consistent with this IR spectrum, since an intense band at 896 cm -1 is observed, which can be assigned to the (Re=O) vibration. 55 The Therefore, we can suppose that the acid generated by the reaction with the carboxylic hydrogen atom is responsible for the protonation of the piperazine nitrogens. The absence of free ciprofloxacin in this complex is evidenced by the IR spectrum (no signal is observed at 1730 cm -1 ), and this fact agrees with the idea that the reaction at a lower temperature minimises the presence of free ciprofloxacin in the final product.
(Scheme 4)
Rhenium (I) complex
A rhenium carbonyl complex with ciprofloxacin was prepared by direct reaction 57 so it is necessary to maintain this solution at pH neutral or slightly acidic. Furthermore, the acidic medium avoids contaminating the final product by free ciprofloxacin, since the solubility of ciprofloxacin in water is very low at neutral pH, but it is soluble at the pH of the reaction. Complex 3 was obtained as a yellow solid that showed very low solubility in most of the solvents, but it was possible to obtain the ESI-MS spectrum. It shows a peak at 602.2 (m/z) with the characteristic isotopic pattern of rhenium compounds that is assigned to the M+H + -H 2 O signal of complex 3. As in the previous rhenium ciprofloxacin complexes, the 1 H NMR spectrum
gives very little information but shows slight down field shifts of hydrogen atoms of the quinolone ring, which agrees with the coordination of ciprofloxacin through the oxygen atoms of carboxylate and carbonyl groups. This hypothesis agrees with the 13 C CP-MAS spectrum of complex 3, which is very similar to the spectrum of 1 and 2 in the 160-180 ppm region, showing two signals that are assigned to the carbon atoms directly bonded to the oxygen atoms linked to rhenium. 22 The IR spectra also agrees with the proposed coordination for ciprofloxacin, showing two intense signals at 1614 and 1480 cm -1 , in concordance with the observed values for complexes 1-2, and with reported data for other complexes with this coordination. 19, 29, 54 No signal was observed at 1730 cm -1 , showing that this complex is free of contamination with ciprofloxacin and two intense peaks, assigned to the characteristic υ(CO) absorptions of the fac-{Re(CO) 3 } fragment,
are shown at 2018 and 1871 cm -1 . All these data agree with the structure proposed in Scheme 5 for complex 3, in which the ciprofloxacin coordination is identical to that of complexes 1-2, but in this case the metal fragment is fac-{Re(CO) 3 } instead of {ReO 3+ }.
(Scheme 5)
Antimicrobial activity
Antimicrobial activities of the rhenium complexes 2 and 3 were evaluated using the agar disk-diffusion method against Gram-positive and Gram-negative bacteria, and the results are presented in Table 1 . The low solubility of rhenium complexes forces dimethylsulfoxide to be used as solvent and, for that reason, the activity against this molecule is shown. The results reveal that the activity of rhenium complex 2 against all studied strains is nearly identical to that found for the ciprofloxacin, which is used as a reference compound. Alternatively, the activity of the rhenium complex 3 is slightly lower than the activity of the free ciprofloxacin. These results agree with previous reported data about the antimicrobial activity of quinolone metal complexes. Thus, in most of these studies, the reported antimicrobial activities are very similar to, or slightly lower than, those of free quinolones. 19, 23, 54, 58 A c c e p t e d m a n u s c r i p t
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( Table 1) The fact that the rhenium metal complexes of ciprofloxacin exhibits antimicrobial activity can explain the properties of Tc-ciprofloxacin radiopharmaceutical, since the similarities between technetium and rhenium chemistry and between the radiuses of both elements are well known. 1 In other words, if the coordination of the antibiotic to the metal does not significantly alter their antimicrobial properties, it could explain the high concentration of radionuclide in infected regions.
Another interesting result, is to observe that the coordination of ciprofloxacin to the metal fragment fac-{Re(CO) 3 } has more influence on the antimicrobial activity than if it is coordinated to the {ReO 3+ } fragment. We will discuss this result further in the next section.
Inhibition of DNA Gyrase
As previously stated in the introduction, DNA Gyrase is a type II topoisomerase that relaxes supercoiled DNA and also introduces negative supercoils into the double stranded DNA in bacterial replication. The antibacterial properties of quinolones are due to their capability of acting as inhibitors of this enzyme. 7, 10, 59 Different proposals have been made to understand the mechanism of Gyrase inhibition but the molecular details are unknown. 7, 9, 10, 59 It should be mentioned that some authors support the idea that metal atoms are involved in the inhibitions mechanism of Gyrase by quinolones. For this reason, quinolones are also known as metallo-antibiotics, 60 and different studies on
Gyrase inhibition by quinolone metal complexes have been reported. 19, 58, 61, 62 20
Since in 99m Tc-ciprofloxacin radiopharmaceutical the ability to act as a diagnosis agent is a consequence of their antibiotic properties and the presence of the technetium radionuclide, we have performed a study of the Gyrase inhibition by the model rhenium ciprofloxacin complexes in order to obtain experimental data on the inhibition capabilities of the metal complexes.
The study of Escherichia coli topoisomerase II (named DNA Gyrase) inhibition by complexes 2 and 3 was performed by agarose gel electrophoresis using E coli DNA Gyrase cleavage assay kit (Inspiralis) and supercoiled pBR322 plasmid DNA (the study On comparing these results with data obtained for complex 2 (Figure 3 , central image), we can observe a very similar behaviour between this compound and free ciprofloxacin, which points to a inhibition capacity of complex 2 very similar to that of the free antibiotic. In contrast, the analysis of the results obtained with complex 3 (Figure 3 , bottom image) shows that, although this complex also inhibits DNA Gyrase, the behaviour is slightly different than in the other two compounds. Thus, in this case a higher concentration of the tested compound is necessary ( 10 M) to minimise the formation of the different topoisomers that are observed as a ladder in the agar gel.
Consequently, these results are consistent with the observed antimicrobial activity, and confirm that the antibacterial properties of complex 2 are nearly identical to those of the free ciprofloxacin, while complex 3 shows a slightly different behaviour. Hence, although this complex also shows antibacterial properties, exhibits a lower activity than free ciprofloxacin. A c c e p t e d m a n u s c r i p t Tc-ciprofloxacin could be seen as similar to that of the radiopharmaceutical 111 In-oxine, which is known to dissociate after entering the cell. 
